Day 1 - Friday, 13 September 2019
Meeting category
Date(s)
13 Sep 2019 - 14 Sep 2019
Location
Barcelona,
Spain
Organizer
Sponsor logos
European Workshop on Healthy Living with HIV 2019
Related Enduring Materials
Enduring Materials
-
What are the remaining challenges to improve the quality of life of people living HIV?
Session 1: PrEP - from Clinic to Community -
Donn Colby, MD, MPH
Donn Colby, MD, MPH
Chairs
U.S. Military HIV Research Program (MHRP) / Center for Applied Research on Men and Community Health, United States / Vietnam
PrEP - Overcoming Challenges - Lessons from Asia
U.S. Military HIV Research Program (MHRP) / Center for Applied Research on Men and Community Health, United States / Vietnam
PrEP Rollout in Europe - Current Update
PrEP - remaining community needs
Round table discussion:
Implementation status of PrEP
Implementation status of PrEP in Sweden
Anders Sönnerborg
Implementation status of PrEP in France
Daniela Rojas Castro
Session 2: Safe sex practice -
Josep Llibre, MD, PhD
Chairs
Fundació Lluita contra la Sida; Hospital Universitari Germans Trias i Pujol, Spain
Sexual Health Counseling
ChemSex - DDI interactions
Abstract-driven presentations
The relationship between the migration status and the Health-Related Quality of Life (HRQoL) of people living with HIV: a study on the Swedish InfcareHIV cohort from 2011 to 2017
Gaetano Marrone
HIV-related stigma and quality of life outcomes among people living with HIV in the Netherlands
Yvonne Van Der Kooij
Country specific factors determine the quality of life among people with HIV in two western European countries
Stephanie Popping
HIV mental health care: a stepped care model to improve quality of life in people living with HIV
Marie Jose Kleene
An online survey of the quality of life in patients with HIV-infection in Krasnodar
Maxim Konyukhov
Day 2 - Saturday, 14 September 2020
Session 3 Factors affecting Quality of Life -
Chairs
Importance of patient recorded outcomes
Obesity and HIV Treatment - Knowns and unknowns
Abstract-Driven Presentations
HIV and Ageing – Primary and secondary prevention of coronary artery disease among People living with HIV
Gaetano Marrone
Very low sensitivity of Fracture Risk Assessment Tool in young HIV-infected patients: The need for new screening strategies
Berend van Welzen
Current status of HIV: the importance of comorbidities. Do we have to worry about the quality of life of our HIV patients?
Maria Jose Galindo
Break-out Sessions -
Translating resistance and pharmacology to treatment decisions
Using mobile devices to improve Quality of Life
Abstract-driven presentations
e-Health solution characteristics for PLHIV: a Portuguese experience
Gonçalo Lobo
Usability of a Mobile Health Application (“APP”) on Older HIV-Infected Patients: An Emerging Tool for Care, Education and Prevention.
Jordi Puig
Session 4 Future of HIV Treatment -
Chairs
Clinical implications of Long Acting Antivirals
Overview
Welcome
"To help the European community of future clinical leaders, who embrace an updated and relevant paradigm for the optimal care of HIV infected individuals. Focused not only on viral suppression but also on guaranteeing them optimal health throughout their lifetime. Striving to develop a clinical setting where treatment decisions consider all their implications for long term health."
Over the last two decades, HIV has been transformed from a fatal disease into a chronic condition where the great majority of HIV infected individuals can look forward to a full and active life. This has been due to an increased understanding of the disease and its management, but above all to the unprecedented improvement in antiretroviral drugs.
Not surprisingly, current management of HIV infected patients continues to be overwhelmingly influenced by the fear of AIDS, suffering and death, with treatment success measured by long term avoidance of these conditions. But in the context of the armamentarium now available to clinicians and HIV infected individuals, much loftier goals are appropriate. Clinicians should now be focused not only on avoiding AIDS but on guaranteeing HIV infected individuals a full long life with a very minimum of adverse events or co-morbidities. Planning not only for the next 5 – 10 years but for many decades to come with a healthy and productive older age. This requires clinicians adapt a proactive approach to preventing long term morbidities and incorporate this into their decision-making process when making treatment choices.
Program Chairs
General Information
Meeting Objectives
This meeting aims to:
- Educate HIV clinicians on new treatment options and their long-term implications;
- Increase the HIV clinician’s level of understanding of options for prevention of comorbidities and adverse events;
- Help shift the clinician’s focus to management of long-term health;
- Encourage a proactive and protective treatment attitude;
- Broaden the scope of HIV clinicians and enrich their knowledge of and collaboration with other medical disciplines.
- Educate HIV clinicians on new treatment options and their long-term implications;
- Increase the HIV clinician’s level of understanding of options for prevention of comorbidities and adverse events;
- Help shift the clinician’s focus to management of long-term health;
- Encourage a proactive and protective treatment attitude;
- Broaden the scope of HIV clinicians and enrich their knowledge of and collaboration with other medical disciplines.
Learning Objectives
After participating in this activity, participants will be able to:
- Enhanced communication and collaboration between both junior- and senior-level international researchers (from academia, government, and industry) and clinicians to promote the exchange of ideas, results, and technologies leading to successful translation into improving long term health for HIV-positive individuals;
- Dissemination of knowledge and data exchanged by conference participants beyond the audience of the live event, thus maximizing the impact on the HIV research community.
- Enhanced communication and collaboration between both junior- and senior-level international researchers (from academia, government, and industry) and clinicians to promote the exchange of ideas, results, and technologies leading to successful translation into improving long term health for HIV-positive individuals;
- Dissemination of knowledge and data exchanged by conference participants beyond the audience of the live event, thus maximizing the impact on the HIV research community.
Practical Information
Certificate of Attendance
A certificate of attendance was sent to participants that successfully completed the program and post-meeting survey.
Language
The official language of the workshop was English.
Disclaimer
This workshop is intended for educational purposes only and aims to offer participants the opportunity to share information. The Organizing Secretariat of this workshop, Virology Education, cannot accept any liability for the scientific content of the sessions or for any claims which may result from the use of information or publications from this workshop. Virology Education disclaims all liability for injuries or losses of whatever nature incurred by individuals attending the workshop.
Liability and Insurance
By registering for the workshop participants agree that the organizers do not accept responsibility for medical-, travel- or personal insurance. Participants are advised to take out their own insurance policies.
Photographs, Audio, and Video Recording
Photographs, audio, and video recordings are not permitted at the official workshop sessions. Only the official medical writer appointed by the organization may make recordings. All presentations will be posted here as soon as possible after the workshop is finished, provided the speaker has given permission to do so.
Committees
Scientific Committee
The members of Scientific Committee are hand-picked by the Organizing Committee and the conference secretariat based on their significant contributions and commitment to the field. They assist the Organizing Committee by providing them with suggestions for speakers and topics. In addition, members of the Scientific Committee participate in reviewing submitted abstracts, and play an active role during the workshop as moderators and/or chairs of sessions.
Support
Funding Father
Gold Level
Endorsers
Language
Related Programs
